Journal of Biosciences

, Volume 28, Issue 3, pp 323–335 | Cite as

HIV-1 Nef control of cell signalling molecules: Multiple strategies to promote virus replication

  • Alison L. GreenwayEmail author
  • Gavan Holloway
  • Dale A. McPhee
  • Phoebe Ellis
  • Alyssa Cornall
  • Michael Lidman


HIV-1 has at its disposal numerous proteins encoded by its genome which provide the required arsenal to establish and maintain infection in its host for a considerable number of years. One of the most important and enigmatic of these proteins is Nef. The Nef protein of HIV-1 plays a fundamental role in the virus life cycle. This small protein of approximately 27 kDa is required for maximal virus replication and disease progression. The mechanisms by which it is able to act as a positive factor during virus replication is an area of intense research and although some controversy surrounds Nef much has been gauged as to how it functions. Its ability to modulate the expression of key cellular receptors important for cell activation and control signal transduction elements and events by interacting with numerous cellular kinases and signalling molecules, including members of the Src family kinases, leading to an effect on host cell function is likely to explain at least in part its role during infection and represents a finely tuned mechanism where this protein assists HIV-1 to control its host.


HIV-1 Nef pathogenesis signal transduction 

Abbreviations used


Adapter protein


cytotoxic T-lymphocytes


IL-2 receptor


p21-activated kinase 2


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aiken C, Konner J, Landau N R, Lenburg M E and Trono D 1994 Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain;Cell 76 853–864PubMedCrossRefGoogle Scholar
  2. Arold S, Franken P, Strub M P, Hoh F, Benichou S, Benarous R and Dumas C 1997 The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling;Structure 5 1361–1372PubMedCrossRefGoogle Scholar
  3. Arora V K, Molina R P, Foster J L, Blakemore J L, Chernoff J, Fredericksen B L and Garcia J V 2000 Lentivirus Nef specifically activates Pak2;J. Virol. 74 11081–11087PubMedPubMedCentralCrossRefGoogle Scholar
  4. Bandres J C and Ratner L 1994 Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T-cells in vitro after T-cell receptor stimulation;J. Virol. 68 3243–3249PubMedPubMedCentralGoogle Scholar
  5. Baur A S, Sass G, Laffert B, Willbold D, Cheng-Mayer C and Peterlin B M 1997 The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase;Immunity 6 283–291PubMedCrossRefGoogle Scholar
  6. Baur A S, Sawai E T, Dazin P, Fantl W J, Cheng-Mayer C and Peterlin B M 1994 HIV-1 Nef leads to inhibition or activation of T-cells depending on its intracellular localization;Immunity 1 373–384PubMedCrossRefGoogle Scholar
  7. Beaty C D, Franklin T L, Uehara Y and Wilson C B 1994 Lipopolysaccharide-induced cytokine production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction;Eur. J. Immunol. 24 1278–1284PubMedCrossRefGoogle Scholar
  8. Bell I, Schaefer T M, Trible R P, Amedee A and Reinhart T A 2001 Down-modulation of the costimulatory molecule, CD28, is a conserved activity of multiple SIV Nefs and is dependent on histidine 196 of Nef;Virology 283 148–158PubMedCrossRefGoogle Scholar
  9. Benichou S, Liu L X, Erdtmann L, Selig L and Benarous R 1997 Use of the two-hybrid system to identify cellular partners of the HIV1 Nef protein;Res. Virol. 148 71–73PubMedCrossRefGoogle Scholar
  10. Benson R E, Sanfridson A, Ottinger J S, Doyle C and Cullen B R 1993 Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection;J. Exp. Med. 177 1561–1566PubMedCrossRefGoogle Scholar
  11. Bodeus M, Marie-Cardine A, Bougeret C, Ramos-Morales F and Benarous R 1995 In vitro binding and phosphorylation of human immunodeficiency virus type 1 Nef protein by serine/threonine protein kinase;J. Gen. Virol. 76 1337–1344PubMedCrossRefGoogle Scholar
  12. Bolen J B, Rowley R B, Spana C and Tsygankov A Y 1992 The Src family of tyrosine protein kinases in hemopoietic signal transduction;Faseb J. 6 3403–3409PubMedCrossRefGoogle Scholar
  13. Brady H J, Pennington D J, Miles C G and Dzierzak E A 1993 CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration;EMBO J. 12 4923–4932PubMedPubMedCentralCrossRefGoogle Scholar
  14. Briggs S D, Scholtz B, Jacque J M, Swingler S, Stevenson M and Smithgall T E 2001 HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway;J. Biol. Chem. 276 25605–25611PubMedCrossRefGoogle Scholar
  15. Briggs S D, Sharkey M, Stevenson M and Smithgall TE 1997 SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1;J. Biol. Chem. 272 17899–17902PubMedCrossRefGoogle Scholar
  16. Brown A, Wang X, Sawai E and Cheng-Mayer C 1999 Activation of the PAK-related kinase by human immunodeficiency virus type 1 Nef in primary human peripheral blood lymphocytes and macrophages leads to phosphorylation of a PIX-p95 complex;J. Virol. 73 9899–9907PubMedPubMedCentralGoogle Scholar
  17. Campbell S M, Crowe S M and Mak J 2001 Lipid rafts and HIV-1: from viral entry to assembly of progeny virions;J. Clin. Virol. 22 217–227PubMedCrossRefGoogle Scholar
  18. Chang A H, O’Shaughnessy M V and Jirik F R 2001 Hck SH3 domain-dependent abrogation of Nef-induced class 1 MHC down-regulation;Eur. J. Immunol. 31 2382–2387PubMedCrossRefGoogle Scholar
  19. Chen B K, Gandhi R T and Baltimore D 1996 CD4 downmodulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef;J. Virol. 70 6044–6053PubMedPubMedCentralGoogle Scholar
  20. Cheng H, Hoxie J P and Parks W P 1999 The conserved core of human immunodeficiency virus type 1 Nef is essential for association with Lck and for enhanced viral replication in T-lymphocytes;Virology 264 5–15PubMedCrossRefGoogle Scholar
  21. Coates K, Cooke S J, Mann D A and Harris M P G 1997 Protein kinase C-mediated phosphorylation of HIV-I nef in human cell lines;J. Biol. Chem. 272 12289–12294PubMedCrossRefGoogle Scholar
  22. Collette Y, Arold S, Picard C, Janvier K, Benichou S, Benarous R, Olive D and Dumas C 2000 HIV-2 and SIV nef proteins target different Src family SH3 domains than does HIV-1 Nef because of a triple amino acid substitution;J. Biol. Chem. 275 4171–4176PubMedCrossRefGoogle Scholar
  23. Collette Y, Dutartre H, Benziane A, Ramos M, Benarous R, Harris M and Olive D 1996 Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects;J. Biol. Chem. 271 6333–6341PubMedCrossRefGoogle Scholar
  24. Collette Y and Olive D 1999 The primate lentivirus-encoded Nef protein can regulate several steps of the viral replication cycle;Virology 265 173–177PubMedCrossRefGoogle Scholar
  25. Collins K L, Chen B K, Kalams S A, Walker B D and Baltimore D 1998 HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes;Nature (London) 391 397–401CrossRefGoogle Scholar
  26. Craig H M, Pandori M W and Guatelli J C 1998 Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity;Proc. Natl. Acad. Sci. USA 95 11229–11234PubMedCrossRefGoogle Scholar
  27. Crise B and Rose J K 1992 Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum;J. Virol. 66 2296–2301PubMedPubMedCentralGoogle Scholar
  28. De S K and Marsh J W 1994 HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells;J. Biol. Chem. 269 6656–6660PubMedGoogle Scholar
  29. De S K, Venkateshan C N, Seth P, Gajdusek D C and Gibbs C J 1998 Adenovirus-mediated human immunodeficiency virus-1 Nef expression in human monocytes/macrophages and effect of Nef on downmodulation of Fcgamma receptors and expression of monokines;Blood 91 2108–2117PubMedGoogle Scholar
  30. Deacon N J, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker D J, McPhee D A, Greenway A L, Ellett A, Chatfield C, Larison V A, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan J S, Cunningham A, Dwyer D, Dowton D and Mills J 1995 Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients [see comments];Science 270 988–991PubMedCrossRefGoogle Scholar
  31. Dutartre H, Harris M, Olive D and Collette Y 1998 The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism;Virology 247 200–211PubMedCrossRefGoogle Scholar
  32. Ernst C A, Zhang Y J, Hancock P R, Rutledge B J, Corless C L and Rollins B J 1994 Biochemical and biologic characterization of murine monocyte chemoattractant protein-1. Identification of two functional domains;J. Immunol. 152 3541–3549PubMedGoogle Scholar
  33. Fackler O T, Luo W, Geyer M, Alberts A S and Peterlin B M 1999 Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions;Mol. Cell 3 729–739PubMedCrossRefGoogle Scholar
  34. Fauci A S 1988 The human immunodeficiency virus: infectivity and mechanisms of pathogenesis;Science 239 617–622PubMedCrossRefGoogle Scholar
  35. Flaherty M T, Barber S A and Clements J E 1998 Neurovirulent simian immunodeficiency virus incorporates a Nef-associated kinase activity into virions;AIDS Res. Hum. Retroviruses 14 163–170PubMedCrossRefGoogle Scholar
  36. Frank S J, Samelson L E and Klausner R D 1990 The structure and signalling functions of the invariant T cell receptor components;Semin. Immunol. 2 89–97PubMedGoogle Scholar
  37. Garcia J V, Alfano J and Miller A D 1993 The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4;J. Virol. 67 1511–1516PubMedPubMedCentralGoogle Scholar
  38. Garcia J V and Miller A D 1991 Serine phosphorylation-independent downregulation of cell-surface CD4 by nef;Nature (London) 350 508–511CrossRefGoogle Scholar
  39. Geleziunas R, Xu W, Takeda K, Ichijo H and Greene W C 2001 HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell;Nature (London) 410 834–838CrossRefGoogle Scholar
  40. Gratton S, Yao X J, Venkatesan S, Cohen E A and Sekaly R P 1996 Molecular analysis of the cytoplasmic domain of CD4: overlapping but noncompetitive requirement for lck association and down-regulation by Nef;J. Immunol. 157 3305–3311PubMedGoogle Scholar
  41. Greenberg M, DeTulleo L, Rapoport I, Skowronski J and Kirchhausen T 1998 A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4;Curr. Biol. 8 1239–1242PubMedCrossRefGoogle Scholar
  42. Greenberg M E, Bronson S, Lock M, Neumann M, Pavlakis G N and Skowronski J 1997 Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nefinduced CD4 down-regulation;EMBO J. 16 6964–6976PubMedPubMedCentralCrossRefGoogle Scholar
  43. Greenway A, Azad A and McPhee D 1995 Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines;J. Virol. 69 1842–1850PubMedPubMedCentralGoogle Scholar
  44. Greenway A, Azad A, Mills J and McPhee D 1996 Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity;J. Virol. 70 6701–6708PubMedPubMedCentralGoogle Scholar
  45. Greenway A L, Dutartre H, Allen K, McPhee D A, Olive D and Collette Y 1999 Simian immunodeficiency virus and human immunodeficiency virus type 1 nef proteins show distinct patterns and mechanisms of Src kinase activation;J. Virol. 73 6152–6158PubMedPubMedCentralGoogle Scholar
  46. Greenway A L, McPhee D A, Allen K, Johnstone R, Holloway G, Mills J, Azad A, Sankovich S and Lambert P 2002 Human immunodeficiency virus type 1 Nef binds to tumour suppressor p53 and protects cells against p53-mediated apoptosis;J. Virol. 76 2692–2702PubMedPubMedCentralCrossRefGoogle Scholar
  47. Greenway A L, McPhee D A, Grgacic E, Hewish D, Lucantoni A, Macreadie I and Azad A 1994 Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells;Virology 198 245–256PubMedCrossRefGoogle Scholar
  48. Grzesiek S, Stahl S J, Wingfield P T and Bax A 1996 The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR;Biochemistry 35 10256–10261PubMedCrossRefGoogle Scholar
  49. Gupta D, Jin Y P and Dziarski R 1995 Peptidoglycan induces transcription and secretion of TNF-alpha and activation of lyn, extracellular signal-regulated kinase, and rsk signal transduction proteins in mouse macrophages;J. Immunol. 155 2620–2630PubMedGoogle Scholar
  50. Hanna Z, Kay D G, Rebai N, Guimond A, Jothy S and Jolicoeur P 1998 Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice;Cell 95 163–175PubMedCrossRefGoogle Scholar
  51. Hanna Z, Weng X, Kay D G, Poudrier J, Lowell C and Jolicoeur P 2001 The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck;J. Virol. 75 9378–9392PubMedPubMedCentralCrossRefGoogle Scholar
  52. Harris M P and Neil J C 1994 Myristoylation-dependent binding of HIV-1 Nef to CD4;J. Mol. Biol. 241 136–142PubMedCrossRefGoogle Scholar
  53. Holly S P and Blumer K J 1999 PAK-family kinases regulate cell and actin polarization throughout the cell cycle ofSaccharomyces cerevisiae;J. Cell. Biol. 147 845–856PubMedPubMedCentralCrossRefGoogle Scholar
  54. Holstein S E, Drucker M and Robinson D G 1994 Identification of a beta-type adaptin in plant clathrin-coated vesicles;J. Cell. Sci. 107 945–953PubMedGoogle Scholar
  55. Horak I D, Gress R E, Lucas P J, Horak E M, Waldmann T A and Bolen J B 1991 T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck;Proc. Natl. Acad. Sci. USA 88 1996–2000PubMedCrossRefGoogle Scholar
  56. Iafrate A J, Bronson S and Skowronski J 1997 Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling;EMBO J. 16 673–684PubMedPubMedCentralCrossRefGoogle Scholar
  57. Jacque J M, Mann A, Enslen H, Sharova N, Brichacek B, Davis R J and Stevenson M 1998 Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase;EMBO J. 17 2607–2618PubMedPubMedCentralCrossRefGoogle Scholar
  58. Jakobi R, Moertl E and Koeppel M A 2001 p21-activated protein kinase gamma-PAK suppresses programmed cell death of BALB3T3 fibroblasts;J. Biol. Chem. 276 16624–16634PubMedCrossRefGoogle Scholar
  59. Kamp W, Berk M B, Visser C J and Nottet H S 2000 Mechanisms of HIV-1 to escape from the host immune surveillance;Eur. J. Clin. Invest. 30 740–746PubMedCrossRefGoogle Scholar
  60. Kestler H W D, Ringler D J, Mori K, Panicali D L, Sehgal P K, Daniel M D and Desrosiers R C 1991 Importance of the nef gene for maintenance of high virus loads and for development of AIDS;Cell 65 651–662PubMedCrossRefGoogle Scholar
  61. Kirchhoff F, Greenough T C, Brettler D B, Sullivan J L and Desrosiers R C 1995 Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection [see comments];N. Engl. J. Med. 332 228–232PubMedCrossRefGoogle Scholar
  62. Le Gall S, Erdtmann L, Benichou S, Berlioz-Torrent C, Liu L, Benarous R, Heard J M and Schwartz O 1998 Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules;Immunity 8 483–495CrossRefGoogle Scholar
  63. Le Gall S, Heard J M and Schwartz O 1997 Analysis of Nefinduced MHC-I endocytosis;Res. Virol. 148 43–47CrossRefGoogle Scholar
  64. Lee C H, Leung B, Lemmon M A, Zheng J, Cowburn D, Kuriyan J and Saksela K 1995 A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein;EMBO J. 14 5006–5015PubMedPubMedCentralCrossRefGoogle Scholar
  65. Lee C H, Saksela K, Mirza U A, Chait B T and Kuriyan J 1996 Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain;Cell 85 931–942PubMedCrossRefGoogle Scholar
  66. Letourneur F and Klausner R D 1992 A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains;Cell 69 1143–1157PubMedCrossRefGoogle Scholar
  67. Lock M, Greenberg M E, Iafrate A J, Swigut T, Muench J, Kirchhoff F, Shohdy N and Skowronski J 1999 Two elements target SIV Nef to the AP-2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis;EMBO J. 18 2722–2733PubMedPubMedCentralCrossRefGoogle Scholar
  68. Luria S, Chambers I and Berg P 1991 Expression of the type 1 human immunodeficiency virus Nef protein in T-cells prevents antigen receptor-mediated induction of interleukin 2 mRNA;Proc. Natl. Acad. Sci. USA 88 5326–5330PubMedCrossRefGoogle Scholar
  69. Mangasarian A, Foti M, Aiken C, Chin D, Carpentier J L and Trono D 1997 The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane;Immunity 6 67–77PubMedCrossRefGoogle Scholar
  70. Mangasarian A, Piguet V, Wang J K, Chen Y L and Trono D 1999 Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking;J. Virol. 73 1964–1973PubMedPubMedCentralGoogle Scholar
  71. Manninen A, Hiipakka M, Vihinen M, Lu W, Mayer B J and Saksela K 1998 SH3-Domain binding function of HIV-1 Nef is required for association with a PAK-related kinase;Virology 250 273–282PubMedCrossRefGoogle Scholar
  72. Manninen A, Renkema G H and Saksela K 2000 Synergistic activation of NFAT by HIV-1 nef and the Ras/MAPK pathway;J. Biol. Chem. 275 16513–16517PubMedCrossRefGoogle Scholar
  73. Mariani R and Skowronski J 1993 CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals;Proc. Natl. Acad. Sci. USA 90 5549–5553PubMedCrossRefGoogle Scholar
  74. Miller M D, Warmerdam M T, Gaston I, Greene W C and Feinberg M B 1994 The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages;J. Exp. Med. 179 101–113PubMedCrossRefGoogle Scholar
  75. Minami Y, Kono T, Yamada K, Kobayashi N, Kawahara A, Perlmutter R M and Taniguchi T 1993 Association of p56lck with IL-2 receptor beta chain is critical for the IL-2-induced activation of p56lck;EMBO J. 12 759–768PubMedPubMedCentralCrossRefGoogle Scholar
  76. Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee C H, Kuriyan J and Miller W T 1997 Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement [see comments];Nature (London) 385 650–653CrossRefGoogle Scholar
  77. Mountz J D, Zhou T, Wu J, Wang W, Su X and Cheng J 1995 Regulation of apoptosis in immune cells;J. Clin. Immunol. 15 1–16PubMedCrossRefGoogle Scholar
  78. Niederman T M, Hastings W R, Luria S, Bandres J C and Ratner L 1993 HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells;Virology 194 338–344PubMedCrossRefGoogle Scholar
  79. Nunn M F and Marsh J W 1996 Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family;J. Virol. 70 6157–6161PubMedPubMedCentralGoogle Scholar
  80. Ono A and Freed E O 2001 Plasma membrane rafts play a critical role in HIV-1 assembly and release;Proc. Natl. Acad. Sci. USA 98 13925–13930PubMedCrossRefGoogle Scholar
  81. Oyaizu N, Than S, McCloskey T W and Pahwa S 1995 Requirement of p56lck in T-cell receptor/CD3-mediated apoptosis and Fas-ligand induction in Jurkat cells;Biochem. Biophys. Res. Commun. 213 994–1001PubMedCrossRefGoogle Scholar
  82. Pandori M, Craig H, Moutouh L, Corbeil J and Guatelli J 1998 Virological importance of the protease-cleavage site in human immunodeficiency virus type 1: Nef is independent of both intravirion processing and CD4 down-regulation;Virology 251 302–316PubMedCrossRefGoogle Scholar
  83. Pandori M W, Fitch N J, Craig H M, Richman D D, Spina C A and Guatelli J C 1996 Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein;J. Virol. 70 4283–4290PubMedPubMedCentralGoogle Scholar
  84. Piguet V, Chen Y L, Mangasarian A, Foti M, Carpentier J L and Trono D 1998 Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes;EMBO J. 17 2472–2481PubMedPubMedCentralCrossRefGoogle Scholar
  85. Piguet V, Gu F, Foti M, Demaurex N, Gruenberg J, Carpentier J L and Trono D 1999a Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes;Cell 97 63–73PubMedCrossRefGoogle Scholar
  86. Piguet V, Schwartz O, Le Gall S and Trono D 1999b The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors;Immunol. Rev. 168 51–63PubMedCrossRefGoogle Scholar
  87. Piguet V and Trono D 1999 The Nef protein of primate lentiviruses;Rev. Med. Virol. 9 111–120PubMedCrossRefGoogle Scholar
  88. Renkema G H, Manninen A and Saksela K 2001 Human immunodeficiency virus type 1 Nef selectively associates with a catalytically active subpopulation of p21-activated kinase 2 (PAK2) independently of PAK2 binding to Nck or beta-PIX;J. Virol. 75 2154–2160PubMedPubMedCentralCrossRefGoogle Scholar
  89. Rhee S S and Marsh J W 1994 HIV-1 Nef activity in murine T-cells. CD4 modulation and positive enhancement;J. Immunol. 152 5128–5134PubMedGoogle Scholar
  90. Riggs N L, Craig H M, Pandori M W and Guatelli J C 1999 The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC;Virology 258 203–207PubMedCrossRefGoogle Scholar
  91. Rousso I, Mixon M B, Chen B K and Kim P S 2000 Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity;Proc. Natl. Acad. Sci. USA 97 13523–13525PubMedCrossRefGoogle Scholar
  92. Rudd C E, Trevillyan J M, Dasgupta J D, Wong L L and Schlossman S F 1988 The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp 58) from human T lymphocytes;Proc. Natl. Acad. Sci. USA 85 5190–5194CrossRefPubMedGoogle Scholar
  93. Saksela K, Cheng G and Baltimore D 1995 Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4;EMBO J. 14 484–491PubMedPubMedCentralCrossRefGoogle Scholar
  94. Salghetti S, Mariani R and Skowronski J 1995 Human immunodeficiency virus type 1 Nef and p56lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail;Proc. Natl. Acad. Sci. USA 92 349–353PubMedCrossRefGoogle Scholar
  95. Sawai E T, Baur A S, Peterlin B M, Levy J A and Cheng-Mayer C 1995 A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity;J. Biol. Chem. 270 15307–15314PubMedCrossRefGoogle Scholar
  96. Sawai E T, Baur A, Struble H, Peterlin B M, Levy J A and Cheng-Mayer C 1994 Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes;Proc. Natl. Acad. Sci. USA 91 1539–1543PubMedCrossRefGoogle Scholar
  97. Sawai E T, Khan I H, Montbriand P M, Peterlin B M, Cheng-Mayer C and Luciw P A 1996 Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques;Curr. Biol. 6 1519–1527PubMedCrossRefGoogle Scholar
  98. Schrager J A and Marsh J W 1999 HIV-1 Nef increases T-cell activation in a stimulus-dependent manner;Proc. Natl. Acad. Sci. USA 96 8167–8172PubMedCrossRefGoogle Scholar
  99. Schwartz O, Marechal V, Danos O and Heard J M 1995 Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell;J. Virol. 69 4053–4059PubMedPubMedCentralGoogle Scholar
  100. Schwartz O, Marechal V, Le Gall S, Lemonnier F and Heard J M 1996 Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein;Nat. Med. 2 338–342PubMedCrossRefGoogle Scholar
  101. Simard M C, Chrobak P, Kay D G, Hanna Z, Jothy S and Jolicoeur P 2002 Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease;J. Virol. 76 3981–3995PubMedPubMedCentralCrossRefGoogle Scholar
  102. Simmons A, Aluvihare V and McMichael A 2001 Nef triggers a transcriptional program in T-cells imitating singlesignal T cell activation and inducing HIV virulence mediators;Immunity 14 763–777PubMedCrossRefGoogle Scholar
  103. Skowronski J, Parks D and Mariani R 1993 Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene;EMBO J. 12 703–713PubMedPubMedCentralCrossRefGoogle Scholar
  104. Smith B L, Krushelnycky B W, Mochly-Rosen D and Berg P 1996 The HIV nef protein associates with protein kinase C theta;J. Biol. Chem. 271 16753–16757PubMedCrossRefGoogle Scholar
  105. Swigut T, Shohdy N and Skowronski J 2001 Mechanism for down-regulation of CD28 by Nef;EMBO J. 20 1593–1604PubMedPubMedCentralCrossRefGoogle Scholar
  106. Swingler S, Mann A, Jacque J, Brichacek B, Sasseville V G, Williams K, Lackner A A, Janoff E N, Wang R, Fisher D and Stevenson M 1999 HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages;Nat. Med. 5 997–1103PubMedCrossRefGoogle Scholar
  107. Van Parijs L, Peterson D A and Abbas A K 1998 The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens;Immunity 8 265–274PubMedCrossRefGoogle Scholar
  108. Veillette A, Horak I D, Horak E M, Bookman M A and Bolen J B 1988 Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activation;Mol. Cell. Biol. 8 4353–4361PubMedPubMedCentralCrossRefGoogle Scholar
  109. Weiss A 1993 T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases;Cell 73 209–212PubMedCrossRefGoogle Scholar
  110. Weiss A and Littman D R 1994 Signal transduction by lymphocyte antigen receptors;Cell 76 263–274PubMedCrossRefGoogle Scholar
  111. Weiss A, Wiskocil R L and Stobo J D 1984 The role of T3 surface molecules in the activation of human T cells: a twostimulus requirement for IL 2 production reflects events occurring at a pre-translational level;J. Immunol. 133 123–128PubMedGoogle Scholar
  112. Willey R L, Maldarelli F, Martin M A and Strebel K 1992 Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes;J. Virol. 66 226–234PubMedPubMedCentralGoogle Scholar
  113. Wiskerchen M and Cheng-Mayer C 1996 HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis;Virology 224 292–301PubMedCrossRefGoogle Scholar
  114. Wolf D, Witte V, Laffert B, Blume K, Stromer E, Trapp S, d’Aloja P, Schurmann A and Baur A S 2001 HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals;Nat. Med. 7 1217–1224PubMedCrossRefGoogle Scholar
  115. Xu X N, Laffert B, Screaton G R, Kraft M, Wolf D, Kolanus W, Mongkolsapay J, McMichael A J and Baur A S 1999 Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain;J. Exp. Med. 189 1489–1496PubMedPubMedCentralCrossRefGoogle Scholar
  116. Yoon K, Jeong J G and Kim S 2001 Stable expression of human immunodeficiency virus type 1 Nef confers resistance against Fas-mediated apoptosis;AIDS Res. Hum. Retroviruses 17 99–104PubMedCrossRefGoogle Scholar
  117. Zang M, Waelde C A, Xiang X, Rana A, Wen R and Luo Z 2001 Microtubule integrity regulates Pak leading to Rasindependent activation of Raf-1. Insights into mechanisms of Raf-1 activation;J. Biol. Chem. 276 25157–25165PubMedCrossRefGoogle Scholar
  118. Zhou J and Aiken C 2001 Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope;J. Virol. 75 5851–5859PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Indian Academy of Sciences 2003

Authors and Affiliations

  • Alison L. Greenway
    • 1
    Email author
  • Gavan Holloway
    • 1
  • Dale A. McPhee
    • 1
  • Phoebe Ellis
    • 1
  • Alyssa Cornall
    • 1
  • Michael Lidman
    • 1
  1. 1.AIDS Cellular Biology UnitMacfarlane Burnet Institute for Medical Research and Public HealthMelbourneAustralia

Personalised recommendations